Qualys Inc header image

Qualys Inc

QLYS

Equity

ISIN US74758T3032 / Valor 19549949

NASDAQ (2024-11-22)
USD 153.37+2.12%

Qualys Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Qualys Inc, founded in 1999, is a pioneering firm in the Software as a Service (SaaS) security sector, leveraging its early entry into cloud-based security to establish itself as a key player in the cybersecurity landscape. The company has formed strategic partnerships with major cloud providers such as Amazon Web Services, Microsoft Azure, and Google Cloud Platform, as well as with a wide array of managed service providers and consulting organizations including Accenture, BT, and IBM, among others. This network of partnerships underscores Qualys' integral role in the cybersecurity ecosystem, providing a broad security product portfolio that addresses a range of digital security needs. Under the leadership of industry veterans like CEO Sumedh Thakar, who has been with the company since 2003, Qualys has focused on developing and enhancing its offerings to help organizations navigate the complexities of securing their digital assets in the cloud era. The company's executive team, with extensive experience across cybersecurity disciplines, drives innovation and operational excellence, ensuring Qualys remains at the forefront of the industry in providing scalable, cloud-based security solutions.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (14.08.2024):

Revenue Growth

Qualys Inc. reported revenues of $148.7 million for the second quarter of 2024, marking an 8% increase compared to $137.2 million for the same quarter in 2023. This growth underscores the company's expanding market presence and customer base.

Net Income

For the second quarter of 2024, Qualys Inc. achieved a GAAP net income of $43.8 million, or $1.17 per diluted share. This represents a 24% increase compared to $35.4 million, or $0.95 per diluted share, for the same quarter in 2023.

Operating Income

Qualys Inc.'s GAAP operating income for the second quarter of 2024 increased by 12% to $48.1 million compared to $42.8 million for the same quarter in 2023. As a percentage of revenues, GAAP operating income was 32% for the second quarter of 2024, up from 31% in the same quarter of the previous year.

Adjusted EBITDA

Adjusted EBITDA for Qualys Inc. in the second quarter of 2024 was $69.9 million, a 6% increase from $65.8 million in the same quarter of 2023. Adjusted EBITDA as a percentage of revenues was 47% for the second quarter of 2024, slightly down from 48% in the same quarter of the previous year.

Financial Outlook

For the third quarter of 2024, Qualys Inc. expects revenues to be in the range of $149.8 million to $151.8 million, representing 5% to 7% growth over the same quarter in 2023. For the full year 2024, the company anticipates revenues between $597.5 million and $601.5 million, reflecting an 8% growth over 2023.

Summarized from source with an LLMView Source

Key figures

-14.4%1Y
16.2%3Y
77.8%5Y

Performance

38.4%1Y
40.6%3Y
41.5%5Y

Volatility

Market cap

5495 M

Market cap (USD)

Daily traded volume (Shares)

131,314

Daily traded volume (Shares)

1 day high/low

151.31 / 147.665

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Sage Therapeutics Inc
Sage Therapeutics Inc Sage Therapeutics Inc Valor: 24747713
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.60%USD 5.17
Gogo Inc
Gogo Inc Gogo Inc Valor: 14665669
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.93%USD 8.12
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc Maravai LifeSciences Holdings Inc Valor: 58353451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.24%USD 5.22
Digital Turbine Inc
Digital Turbine Inc Digital Turbine Inc Valor: 25638656
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.40%USD 1.52
Prime Medicine Inc
Prime Medicine Inc Prime Medicine Inc Valor: 122054714
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.74%USD 3.20
LegalZoom.com Inc
LegalZoom.com Inc LegalZoom.com Inc Valor: 19113587
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.90%USD 7.83
Myriad Genetics Inc
Myriad Genetics Inc Myriad Genetics Inc Valor: 338449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.45%USD 15.49
ABB Ltd
ABB Ltd ABB Ltd Valor: 1222171
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.17%CHF 50.16
BELIMO Holding Ltd
BELIMO Holding Ltd BELIMO Holding Ltd Valor: 110109816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.75%CHF 580.50
SFS Group Ltd
SFS Group Ltd SFS Group Ltd Valor: 23922930
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.47%CHF 124.60